{"id":11147,"date":"2022-12-03T03:45:38","date_gmt":"2022-12-03T03:45:38","guid":{"rendered":"https:\/\/marylanddailygazette.com\/oligonucleotide-synthesis-market-worth-16-7-billion-by-2027-exclusive-report-by-marketsandmarkets\/"},"modified":"2022-12-03T03:45:38","modified_gmt":"2022-12-03T03:45:38","slug":"oligonucleotide-synthesis-market-worth-16-7-billion-by-2027-exclusive-report-by-marketsandmarkets","status":"publish","type":"post","link":"https:\/\/marylanddailygazette.com\/oligonucleotide-synthesis-market-worth-16-7-billion-by-2027-exclusive-report-by-marketsandmarkets\/","title":{"rendered":"Oligonucleotide Synthesis Market worth $16.7 billion by 2027 \u2013 Exclusive Report by MarketsandMarkets\u2122"},"content":{"rendered":"

Oligonucleotide Synthesis Market worth $16.7 billion by 2027 \u2013 Exclusive Report by MarketsandMarkets\u2122<\/a><\/p>\n

\"Oligonucleotide<\/a><\/p>\n
\n

\u201cSome leading players operating in the Oligonucleotide Synthesis Market are Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), LGC Limited (UK), Maravai Life Sciences (US), and Agilent Technologies, Inc. (US).\u201d<\/p>\n<\/div>\n<\/div>\n

Danaher Corporation (US) opened IDT China, an official business entity, to better serve its regional customer base, reach out to new customers, and provide easier access to its complete portfolio of industry-leading products.<\/p>\n

Oligonucleotide Synthesis Market<\/a><\/strong> is projected to reach USD 16.7 billion by 2027 from USD 7.7 billion in 2022, at a CAGR of 16.8% during the forecast period according to a new report by MarketsandMarkets\u2122.<\/strong> One of the key factors driving the market growth is the emerging field of personalized genome sequencing, which helps determine the best approach for patient care, whether preventive, diagnostic, or therapeutic. The incorporation of synthesized oligonucleotides to treat various diseases also supports market growth.<\/p>\n

Download PDF Brochure: https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=200829350<\/a><\/strong><\/p>\n

Browse in-depth TOC on \u201cOligonucleotide Synthesis Market\u201d<\/strong><\/p>\n

236 \u2013 Tables<\/strong><\/p>\n

50 \u2013 Figures<\/strong><\/p>\n

280 \u2013 Pages<\/strong><\/p>\n

Probes accounted for the second-largest segment of the synthesized oligos product segment in 2021.<\/strong><\/p>\n

Probes are an important subsegment in the market for synthesized oligonucleotides. The segment accounted for the second-largest market share due to their important applications in detecting specific nucleic acid sequences and changes occurring in them. Oligos are used as probes in microarrays, in situ hybridization, antisense analyses, and drug carriers.<\/p>\n

Hospitals accounted for the largest share of the end-user segment in the Oligonucleotide Synthesis Market in 2021<\/strong><\/p>\n

By end user, hospitals accounted for the largest share of the Oligonucleotide Synthesis Market in 2021. Growth in this market is largely driven by the significant number of inpatient & outpatient visits in hospitals and the high requirement for oligonucleotide drugs to cater to the growing demand of patients suffering from rare diseases, neurological disorders, and infectious diseases.<\/p>\n

Request Sample Pages: https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=200829350<\/a><\/strong><\/p>\n

The PCR subsegment accounted for the largest share of the research applications segment in the Oligonucleotide Synthesis Market in 2021.<\/strong><\/p>\n

In 2021, PCR accounted for the largest share of the research application subsegment of the Oligonucleotide Synthesis Market. PCR technologies such as qPCR are highly sensitive and cost-effective, driving end-user demand. These PCR applications utilize sequence-specific primers, thus boosting the market for oligos (which are used as probes and primers) in the PCR market.<\/p>\n

Asia Pacific to register the highest CAGR in the Oligonucleotide Synthesis Market<\/strong><\/p>\n

The Asia Pacific region is expected to show the highest CAGR of the Oligonucleotide Synthesis Market. The growth in research outsourcing to emerging countries by pharmaceutical & biotechnology giants, increasing application of genomics in biotechnology & pharmaceutical research, and growing public & private sector investments in genomics and related technologies are expected to aid market growth in the APAC. The growth of the Oligonucleotide Synthesis Market in this region is also fueled by the growing number of domestic drug discovery research projects.<\/p>\n

Some leading players operating in the Oligonucleotide Synthesis Market<\/strong> are Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), LGC Limited (UK), Maravai Life Sciences (US), and Agilent Technologies, Inc. (US).<\/p>\n

Get 10% Free Customization on this Report: https:\/\/www.marketsandmarkets.com\/requestCustomizationNew.asp?id=200829350<\/a><\/strong><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> MarketsandMarkets\u2122 Research Private Ltd.
Contact Person:<\/strong> Mr. Aashish Mehra
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 18886006441
Address:<\/strong>630 Dundee Road Suite 430
City:<\/strong> Northbrook
State:<\/strong> IL 60062
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.marketsandmarkets.com\/Market-Reports\/oligonucleotide-synthesis-market-200829350.html<\/a><\/p>\n

<\/p>\n

Published Fri, 02 Dec 2022 20:00:12 -0600<\/p>\n","protected":false},"excerpt":{"rendered":"

Oligonucleotide Synthesis Market worth $16.7 billion by 2027 \u2013 Exclusive Report by MarketsandMarkets\u2122 \u201cSome leading players operating in the Oligonucleotide Synthesis Market are Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), LGC Limited (UK), Maravai Life Sciences (US), and Agilent Technologies, Inc. (US).\u201d Danaher Corporation (US) opened IDT China, an official business […]<\/p>\n","protected":false},"author":3,"featured_media":11146,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/marylanddailygazette.com\/wp-json\/wp\/v2\/posts\/11147"}],"collection":[{"href":"https:\/\/marylanddailygazette.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/marylanddailygazette.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/marylanddailygazette.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/marylanddailygazette.com\/wp-json\/wp\/v2\/comments?post=11147"}],"version-history":[{"count":0,"href":"https:\/\/marylanddailygazette.com\/wp-json\/wp\/v2\/posts\/11147\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/marylanddailygazette.com\/wp-json\/wp\/v2\/media\/11146"}],"wp:attachment":[{"href":"https:\/\/marylanddailygazette.com\/wp-json\/wp\/v2\/media?parent=11147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/marylanddailygazette.com\/wp-json\/wp\/v2\/categories?post=11147"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/marylanddailygazette.com\/wp-json\/wp\/v2\/tags?post=11147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}